 Antiphospholipid antibodies recurrent pregnancy loss Women antiphospholipid antibodies significant risk reproductive failure adverse pregnancy outcomes incidence recurrent abortion fetal death intrauterine fetal growth retardation significant Women history recurrent abortion unexplained fetal death history recurrent thrombotic episodes presence antiphospholipid antibodies benefit routine screening pregnant women presence antibodies yield studies low treatment regimen fetal loss adverse pregnancy events women antiphospholipid antibody syndrome treatment maternal fetal status Management patients various treatment regimens efficacious Multicenter treatment trials standardization therapy patients